XML 99 R82.htm IDEA: XBRL DOCUMENT v3.24.0.1
Derivative Instruments and Hedging Activities - Summary of Pre-tax (Gains) Losses From Derivatives Designated in Cash Flow Hedging Relationships (Detail) - Designated as Hedging Instrument [Member] - USD ($)
$ in Millions
12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Dec. 31, 2021
Other Comprehensive Income [Member]      
Derivative [Line Items]      
Other comprehensive income (loss) $ 91 $ (270) $ (391)
Financial expenses [Member]      
Derivative [Line Items]      
Financial expenses, net 1,057 966 1,058
Cross Currency Swap Cash Flow Hedge [Member] | Other Comprehensive Income [Member]      
Derivative [Line Items]      
Other comprehensive income (loss) [1] 1 0 0
Cross Currency Swap Cash Flow Hedge [Member] | Financial expenses [Member]      
Derivative [Line Items]      
Financial expenses, net [1] $ (11) $ 0 $ 0
[1] On March 31, 2023, Teva entered into a cross-currency interest rate swap agreement, designated as cash flow hedge for accounting purposes with respect to an intercompany loan due October 2026, denominated in Japanese yen.